Cellectis (CLLS) Said to IPO Calyxt Unit
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) gained pre-market Thursday on talk it plans to IPO its Calyxt unit. Comments about the IPO were made by management at a biotech seminar, according to reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deep Fission (FISN) opens at $16, IPO priced at $16
- L3Harris Missile Arm Said To Tap Banks For Up To $2 Billion IPO - Bloomberg
- SpaceX Bankers Preparing For Bond Sale Of At Least $20 Billion - Bloomberg
Create E-mail Alert Related Categories
IPOs, Management Comments, Spinoffs, Trader TalkRelated Entities
IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
